Featured Pharma Online Editorial
-
Raising The Bar In Radiopharmaceutical Manufacturing
3/12/2026
Ratio Therapeutics chief commercial and manufacturing officer, Scott Holbrook, joined me to discuss how his team at Ratio Therapeutics is tackling the challenges of radiopharmaceutical manufacturing.
-
9 Pharma Trends To Watch In 2026
2/27/2026
What does 2026 ultimately hold for the industry? To explore that question, Lawrence Blatt, CEO of Aligos Therapeutics, sat down with me to share his perspective on the trends shaping the year ahead.
-
The Rise Of The Autonomous Pharma Plant
2/18/2026
What does a production facility of the future look like? That’s exactly what Bayer management asked its team before planning began for the world’s most modern pharmaceutical facility, Solida 1.
-
U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
2/18/2026
Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.
-
Novo's Path To The First GLP-1 Weight Loss Pill
1/23/2026
The race to the finish line for the first oral GLP-1 treatment for weight loss was won on Dec. 22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.
-
Organic Impurities: New Draft ICH Q3E Guidance For Leachables And Extractables
1/17/2026
A new draft guidance document from ICH, issued jointly with the EMA, adopts the position that the assessment of leachables and extractables requires a holistic framework for risk evaluation.
-
An AI Use Case in Pharma Process Optimization
12/18/2025
Recordati Ireland’s production coordinator Ross Fitzgerald took attendees through his team’s AI journey, from identifying the problem to using AI data analytics to find a solution.
-
Gedatolisib Shatters Phase 3 Goals and Scales For Breast Cancer Breakthrough
8/11/2025
After unprecedented phase 3 clinical trails of gedatolisib, Celcuity is working feverishly with its partners to get the drug ready to offer a new standard of care to those that suffer from advanced breast cancer.
-
The Rise Of NAMs
7/31/2025
New Approach Methods (NAMs) are rapidly being accepted as replacements for preclinical animal tests long considered to be the gold standard. NAMs include systems of organoids, organs-on-chips, AI-based prediction models, and non-mammalian species.
-
The 3 Big Barriers To AMT Implementation
7/18/2025
Advanced manufacturing technologies (AMTs) can not only lower costs but also improve the quality and consistency of both API and final dosage manufacturing in pharmaceuticals, so why are they not more widely implemented?